In the TRG 1–2 subgroup (n = 149), although the differences did not reach statistical significance, patients who received ACT showed numerically better survival outcomes than patients who did not receive ACT.
← all excerpts
Impact of perioperative fluorouracil, leucovorin, oxaliplatin, and docetaxel delivery on postoperative survival in locally advanced oesophagogastric adenocarcinoma.
1
—
—